The Georgetown University Center for Children and Families submitted the following comments to CMS regarding the proposed regulation on prior authorization and interoperability. Prior Authorization Comments
Under the highly effective Medicaid Drug Rebate Program (MDRP), drug manufacturers must provide substantial rebates to the federal government and states as a condition of having their drugs covered by Medicaid. For brand-name drugs, the rebates apply to both fee-for-service and Medicaid managed care and consist of two mandatory components. First, under a basic rebate, […]
The pandemic has shed new light on children’s mental health across the nation. While the evidence is clear that even before the COVID pandemic there was a crisis in children’s mental health, the pandemic has further intensified the crisis, as highlighted by national pediatric provider groups in their declaration of a national emergency in child […]
The ancient Roman historian Tacitus wrote that, “It is the singularly unfair peculiarity of war that the credit of success is claimed by all, while a disaster is attributed to one alone.” In the spirit of this observation from 97 AD, I’ll happily admit to trying for at least some historical involvement in North Carolina’s […]
On March 9, the Biden Administration issued its budget plan for fiscal year 2024. Based on budget documents from the Office of Management and Budget (OMB) and the Department of Health and Human Services (HHS), here’s a brief summary of the provisions related to Medicaid and the Children’s Health Insurance Program (CHIP), along with the […]
Kudos to CMS for prompt posting of key dates that states are initiating action as we approach the end of Medicaid continuous eligibility on March 31, 2023. Keep in mind that these dates are “anticipated,” and the document bears a specific date; as such, the list will likely be updated if timelines shift. So, what […]
